Pharmabiz

Pharmabiz is a South Korean specialty pharmaceutical and biotechnology company focused on the development and commercialization of therapies for rare diseases and oncology. Founded in 2003, the company operates a dual business model that combines an internal R&D pipeline of innovative biologics with a robust in-licensing division that brings global orphan drugs to the Korean market. Pharmabiz serves as a strategic partner for international pharmaceutical firms, providing specialized expertise in regulatory affairs, market access, and distribution for high-need therapeutic areas. Its current commercial portfolio includes treatments for metabolic and genetic disorders, while its research efforts are directed toward novel recombinant protein candidates for solid tumors.